Clean home-care start-ups challenge FMCG incumbents as demand shifts to safer, transparent products
Cleevo, Beco and Scrubsy are widening specialised cleaning ranges as Indian shoppers prioritise ingredient safety and product transparency. Quick commerce is speeding distribution, while investors assess margins, repeat purchase and cleaning performance.
What happened
Indian clean home-care start-ups including Cleevo, Beco and Scrubsy are expanding specialised cleaning portfolios as consumers seek safer ingredients and
Key facts
- Cleevo grew 10x between the last and current financial years
- Cleevo targets 7-10x growth
- Scrubsy raised a ₹27 crore seed round
- Clean home-care could become mainstream over the next 3-5 years
Why this matters
FMCG groups should monitor Cleevo, Beco and Scrubsy as potential partnership or acquisition targets that could add credible clean-label positioning ahead of a 3–5 year category inflection.
What to watch
- Repeat purchase rates and 60- to 90-day cohort retention after quick-commerce-led trials.
- Price premium versus mass-market cleaners and whether refill/concentrate formats reduce the gap.
- Evidence of performance parity in independent cleaning, germ-control and stain-removal tests.
- Major FMCG launches featuring ingredient transparency, low-toxin, biodegradable or plant-based claims.
- Quick-commerce assortment expansion, search ranking visibility and platform-funded promotional intensity.
- Gross-margin movement after marketplace commissions, discounts, packaging costs and logistics.
- Regulatory scrutiny or standardised definitions around claims such as non-toxic, natural, chemical-free and biodegradable.
- Seed-to-Series A funding, strategic partnerships or acquisitions in Indian clean home care.
- Expand from hero SKUs into high-frequency use cases such as dishwashing, floor care, laundry additives and bathroom cleaning.
- Prioritise third-party ingredient, safety and efficacy validation to convert transparency claims into purchase trust.
- Use quick-commerce for trial packs, bundles and hyperlocal demand testing, while building subscriptions or refills to reduce dependence on paid acquisition.
- Introduce good-better-best price architecture and concentrated/refill formats to address premium pricing resistance.
- Secure modern trade, pharmacy and offline regional distribution before incumbents flood the segment with clean-label extensions.
- Investors will increasingly underwrite repeat rates, contribution margin after quick-commerce fees, return rates and cohort retention rather than topline growth alone.